BIIB

BIOGEN INC.
ShareXLinkedInReddit
Sector
Health Care
Industry
Biotechnology
Last price
$199.15
As of

Active signals for BIIB

  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 21.5% — EPS $4.81 vs $3.9595 estimate

    All 2026-07-14 signals →
  • mediumEARNINGS_BEAT

    Q2-2025: Beat consensus by 38.9% — EPS $5.47 vs $3.9375 estimate

    All 2026-07-14 signals →
  • mediumEARNINGS_BEAT

    Q1-2026: Beat consensus by 26.3% — EPS $3.57 vs $2.8258 estimate

    All 2026-07-14 signals →
  • mediumEARNINGS_BEAT

    Q4-2025: Beat consensus by 20.9% — EPS $1.99 vs $1.6464 estimate

    All 2026-07-14 signals →
  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — BIOGEN How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs

    All 2026-07-09 signals →

Top institutional holders of BIIB (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$176.3M0.20%+0.1%
Point72 Asset Management, L.P.$140.1M0.23%,
RENAISSANCE TECHNOLOGIES LLC$135.1M0.18%,
RENAISSANCE TECHNOLOGIES LLC$70.3M0.11%-58.6%
TWO SIGMA INVESTMENTS, LP$44.3M0.06%+22.7%
RENAISSANCE TECHNOLOGIES LLC$37.3M0.06%-49.0%
MILLENNIUM MANAGEMENT LLC$36.6M0.02%,
TWO SIGMA INVESTMENTS, LP$28.7M0.04%,
CITADEL ADVISORS LLC$28.5M0.00%+2.5%
CITADEL ADVISORS LLC$22.1M0.00%,
MILLENNIUM MANAGEMENT LLC$19M0.01%+2.8%
MILLENNIUM MANAGEMENT LLC$17.8M0.01%-61.3%
Bridgewater Associates, LP$5.6M0.02%,
TWO SIGMA INVESTMENTS, LP$1.7M0.00%-96.2%
D. E. Shaw & Co., Inc.$1.2M0.00%+0.0%
D. E. Shaw & Co., Inc.$1.1M0.00%-7.2%
D. E. Shaw & Co., Inc.$967K0.00%,
Point72 Asset Management, L.P.$862K0.00%-99.5%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, BIIB

Related tickers

See more BIIB signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track BIIB in your watchlist and get notified the moment a new signal fires.

Track BIIB on Kresmion →